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chapter one
Introduction
Johan Mackenbach and Martin McKee
A natural laboratory
Whatever way one looks at it, Europe is a continent of enormous diversity. 
Despite the powerful forces of globalization, there are still signifi cant differences 
in attitudes, beliefs and lifestyles among the people of Norway in the north, 
Portugal in the west, Malta in the south, the Russian Federation in the east 
and all those in between. These differences are apparent in many ways, from 
their national cuisine, poetry and music, to their health and their wealth. Their 
governments are equally diverse, most obviously in terms of how they see 
the responsibilities of the state and the individual. However, they are, at least 
formally, united in the pursuit of certain shared goals relating to the well-being 
of their people, even if they differ in the means to achieve them.
And they do differ, often quite widely. This is apparent in the choices 
they have made in many policies of direct relevance to health. Some have 
acted resolutely to tackle the enormous toll of disability and premature 
death from tobacco while others have left it to individuals. Some have put 
in place organized systems to detect cancer early and to treat it, while others 
have left it to opportunistic encounters between individuals and their 
physicians. Some have invested in measures to make their roads safe while 
others have not.
This book is about the impact of these differences in health policy on 
population health in Europe since the early 1970s. During these years, the 
health of Europeans overall has improved markedly. Yet that progress has been 
very uneven. While western European countries have experienced gains in life 
expectancy at birth of 7 to 12 years, some in the former USSR have yet to 
recover to the levels reached in 1970. Moreover, within the different parts of 
Europe, countries have varied greatly in what they have achieved.
These variations are even more striking when trends in mortality from 
specifi c conditions, such as cardiovascular diseases, lung and cervical cancer 
or road traffi c injuries (RTIs) are analysed, and they raise important questions 
Book 1.indb   1 12/02/2013   11:07
2 Successes and failures of health policy in Europe
about whether some countries have been more successful in their health 
policies than others. Do between-country differences in rates of smoking-
related diseases refl ect differences in the strictness of tobacco control efforts? 
Do differences in screening policies explain why some countries have higher 
cervical cancer mortality? Are lower rates of RTIs wholly or partly a refl ection of 
more comprehensive road safety programmes?
These questions have never been systematically addressed, and because 
Europe provides a unique ‘natural laboratory’ in which to investigate them, 
this book fi lls an important gap. A comparative analysis of the successes and 
failures of health policy in different European countries is important for 
several reasons. First, it will identify ‘best practices’ from which other countries 
can learn, and which could be implemented more widely in order to improve 
population health throughout Europe. Second, it will make it possible to 
quantify what these policies have achieved and, more importantly, what 
they might achieve in the future. Third, it will be a basis for understanding 
why some countries have succeeded while others have failed to tackle the 
determinants of health among their people, so that others can learn from their 
experiences.
In the remainder of this introductory chapter we will fi rst provide a 
broader context for our comparative analysis of the successes and failures 
of health policy in Europe by briefl y describing recent trends and current 
patterns of health in Europe. We will summarize previous attempts to 
understand what role, if any, purposeful actions by governments and others 
have played in determining the variation. We will then set out the areas of 
health policy that are covered in this book and how the rest of the book will 
be structured.
The unequal health of Europeans
The epidemiological transition
The broader canvas against which we should study the health trends that we 
describe and analyse in this book is the epidemiological transition that European 
populations have undergone during the 20th century. The term ‘epidemiological 
transition’ was fi rst coined in 1971 by Omran, and subsequently modifi ed 
(Omran 1983; Olshansky and Ault 1986; Mackenbach 1994; Vallin and Meslé 
2004), but it still provides a useful framework for characterizing changes in 
population health.
During this transition, which in different parts of Europe began between 1850 
and 1920 (Riley 2001), mortality declined precipitously and life expectancy rose 
in a truly spectacular manner. Originally, three stages were distinguished. In the 
fi rst stage, which Omran called the age of ‘pestilence and famine’, mortality was 
still high, particularly among children, and was mainly caused by infectious 
diseases. In the second stage, which he termed the age of ‘receding pandemics’, 
deaths from infectious diseases declined rapidly and life expectancy started 
to rise. In the third stage, the age of ‘degenerative and man-made diseases’, 
life expectancy continued to rise as a result of further declines in mortality 
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among the young but ultimately reached a plateau because of the simultaneous 
increase in cardiovascular diseases, cancers and RTIs (Omran 1971).
This long-term trend in life expectancy, which extends far beyond the 
period that we are covering in this book, can also clearly be observed in 
European data.
Figure 1.1 illustrates the situation in a few exemplary countries, and also 
shows some of the temporary setbacks in life expectancy coinciding with two 
World Wars and other dramatic historical events.
In the fi rst decades of the 20th century, life expectancy at birth was 
already on the rise in countries in the western part of the European region, 
such as Sweden, England and Wales, Austria, and Italy, so that by 1930 their 
life expectancy surpassed 50 years or, in the case of Sweden, 60 years. In the 
eastern part of the European region, by comparison, the rise of life expectancy 
at birth started much later, but then rose more steeply during the 1940s 
and 1950s so that by 1965 male life expectancy at birth in European 
countries clustered in a narrow range around the age of 70. In a later exten-
sion of his theory, Omran (1983) described the more rapid declines of mortality 
in the eastern parts of the European region as representing an ‘accelerated 
model’, as opposed to the ‘classical model’ seen in the western parts of the 
region.
Figure 1.1 Trends in male life expectancy at birth in Sweden, England and Wales, 
Austria, Italy, Bulgaria and Ukraine, 1900–2008
Source: Human Life-Table Database (2012) except Ukraine (Vallin et al. 2002)
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Figure 1.1 also shows that the period of stagnation of life expectancy that 
corresponds with Omran’s third stage did not last long in the western part 
of the European region and was succeeded by a period of renewed mortality 
decline that started around 1970, justifying the date selected for the analyses 
in this book. This renewed increase of life expectancy resulted from declines 
in mortality from cardiovascular diseases, injury and several other causes; it 
has been called a ‘fourth stage’ of the epidemiological transition in which 
mortality gradually shifts to higher ages (Olshansky and Ault 1986). Others 
prefer to distinguish different transitions (Mackenbach 1994) and to call this 
an entirely new transition, in which cardiovascular diseases may gradually be 
replaced as main causes of death by health conditions of old age such as mental 
and neurological diseases and ‘frailty’ (Vallin and Meslé 2004; Meslé and Vallin 
2006).
What is certain is that this renewed increase of life expectancy has not been 
shared equally between countries, and that life expectancy has diverged again. 
While life expectancy at birth increased during the 1970s and 1980s in the 
western parts of the European Region, it stagnated and even declined somewhat 
in the eastern part of the region, until it fi nally started to rise again in the 
1990s (Central and Eastern Europe) or even later (the former USSR). As a result 
of these diverging developments, life expectancy varies tremendously within 
Europe (Fig. 1.2).
Figure 1.2 Geographical variations in life expectancy at birth in Europe, both 
genders, in quintiles ca. 2008
Source: WHO Regional Offi ce for Europe 2012
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Disease-specifi c patterns
Chronic diseases are now the main cause of death in Europe, the most signifi cant 
among them being ischaemic heart disease, cerebrovascular disease and cancer. 
Over the period 1970–2010, standardized mortality rates for ischaemic heart 
disease and cerebrovascular disease have fallen uniformly in many but not all 
European countries.
There are a number of reasons for this fall in mortality rates, not all fully 
understood. They include reductions in risk factors, such as better diets 
and lower rates of smoking, as well as better treatment and, particularly 
for cerebrovascular disease, control of hypertension. Cerebrovascular disease 
was a condition for which there was no effective treatment until the late 
1950s. An additional factor, most prominent in the former USSR but likely 
to play some role in vulnerable populations in other countries, is hazardous 
alcohol consumption, now recognized as an important cause of sudden 
cardiac death (Tomkins et al. 2012). However, the precise contribution of these 
factors varies over time and from place to place (Ford and Capewell 2011). 
As a result of these disparate developments, current levels of mortality from 
ischaemic heart disease and cerebrovascular disease now differ widely within 
Europe (Fig. 1.3).
Figure 1.3 Geographical variation in mortality from cerebrovascular disease in 
Europe, both genders aged 0–64 years, in quintiles, ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
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Cancer gives rise to a much more complex picture. Although cancer is often 
treated as a single disease, it is in reality simply a description of a biological 
process affecting many different parts of the body, in many different ways, 
all differing greatly in their aetiology and susceptibility to treatment. Like 
ischaemic heart disease and cerebrovascular disease, death rates overall are 
falling, but this conceals some very different trends among men and women in 
different parts of Europe.
Much of this variation results from differing timing of the smoking epidemic 
(Thun et al. 2012). The industrial production of cigarettes, accompanied by 
progressively sophisticated marketing, encouraged a situation in which, by the 
middle of the 20th century, smoking among men in many parts of Europe 
was ubiquitous. Women in western Europe followed this trend, but only after 
a delay of several decades, while cultural norms meant that, until the late 
1980s, smoking among women in what was then the USSR remained rare. This 
has since changed dramatically with the entry of the transnational tobacco 
companies (Gilmore and McKee 2004). The consequences have been successive 
waves of smoking-related cancers across Europe, now fortunately declining 
among men in most countries as the smoking epidemic has begun to recede, 
but still rising among women. These cancers arise not only in the lungs but also 
in the larynx, oesophagus, kidney and bladder, while smoking also increases 
the risk of cancers at other sites, including the cervix.
In contrast, there has been a steady decline in deaths from stomach 
cancer across Europe throughout the past century, refl ecting at least in part 
improvements in hygiene and, specifi cally, a decline in infection with the 
bacterium Helicobacter pylori (Sonnenberg 2010). However, some cancers are 
steadily increasing in incidence, such as cancer of the breast, now the most 
common in women in most countries (except where it is displaced by lung 
cancer). The reasons are thought to include better nutrition and, therefore, 
more rapid growth before puberty (Berkey et al. 2011), changes in patterns of 
child bearing (Hirte et al. 2007), and increased consumption of alcohol among 
women (Seitz et al. 2012).
Given the diversity in causes of cancer, patterns vary markedly. Death rates 
from lung cancer remain high in some western European countries compared 
with the eastern regions, a consequence of the still low rates among women 
in the east, while deaths from cervical cancer are much higher in the east 
(Figs 1.4 and 1.5).
Other non-communicable diseases are of major importance in many parts of 
Europe. They include diabetes mellitus, with increases in both type 1, believed 
to result from an infection with a virus in genetically susceptible individuals 
(Patterson et al. 2009), and type 2, caused primarily by increased levels of 
obesity (Gonzalez et al. 2009). Death rates from chronic obstructive pulmonary 
disease are generally declining, but in western Europe they still vary by a factor 
of more than 10, with the highest rates in Denmark, a country where smoking 
rates remain high.
Death rates from cirrhosis also vary greatly. There is a band of countries in 
south-eastern Europe with particularly high rates, stretching from Slovenia 
through Hungary and Romania to the Republic of Moldova and Ukraine 
(Fig. 1.6). However, overall, rates are declining, although in some cases only in 
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Figure 1.4 Geographical variation in mortality from trachea/bronchus/lung cancer in 
Europe, both genders, all ages, in quintiles ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
Figure 1.5 Geographical variation in female mortality from cervical cancer in Europe, 
all ages, in quintiles, ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
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the very recent past, and there have been some sustained declines in countries 
where rates were once high, such as France.
So far, this description has focused on mortality, largely because of the limited 
amount of data on disability. Yet this gives only a partial picture of the overall 
burden of disease. In particular, it underemphasizes the toll of ill health caused 
by mental illness, even though this is estimated to account for 20% of the total 
burden of disease in Europe. The one measure of mental illness that is available 
in most countries is the death rate from suicide, although, as will be discussed 
later in this book, this is subject to a number of limitations, often arising from 
the stigma that is attached to suicide in many societies. Notwithstanding these 
limitations, there are wide variations within Europe in death rates from suicide 
(Fig. 1.7), as for other causes of death, with the highest rates in the countries of 
the former USSR.
Injuries are the fourth most common cause of death in Europe and one of the 
leading causes of death in childhood. Indeed deaths from injury in childhood 
display one of the steepest gradients between east and west of any cause of death. 
All of these deaths are entirely preventable. Many deaths from injury occur on 
the roads. As we will see later in this book, some countries have made enormous 
progress in reducing these deaths, through a combination of improved transport 
Figure 1.6 Geographical variation in mortality from chronic liver disease and 
cirrhosis in Europe, both genders, all ages, in quintiles ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
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infrastructure, safer vehicles and enforcement of legislation on speed and drunk 
driving. Others, for a variety of reasons, have failed to do so (McKee et al. 2000; 
van Beeck et al. 2000). The east–west divide in injury mortality is stark, but some 
countries in western Europe also have relatively high rates (Fig. 1.8).
Most unintentional injuries occur around the home. Again, substantial gains 
have been made in recent decades in improving safety. Dangerous toys, such 
as those with sharp edges or parts that can be swallowed easily, have been 
withdrawn from sale in most countries. Yet many dangers remain, such as 
those from unguarded play areas, unsafe electrical installations and inadequate 
lighting. As with injuries on the roads, there is still a wide geographical variation.
Although the epidemiological transition has seen remarkable declines in 
infectious diseases over the past century, the struggle between humans and 
microorganisms continues. On several occasions in recent decades, bacteria, 
viruses and the vectors that transmit them have taken advantage of opportunities 
that have arisen. These include the wars in the Balkans in the 1990s and the 
social and economic turmoil that accompanied the dissolution of the USSR 
(Suhrcke et al. 2011), as well as the creation of incubators for tuberculosis in 
overcrowded and poorly maintained prisons (Stuckler et al. 2008). These events 
allowed diseases once considered defeated, such as diphtheria, to re-emerge. 
Figure 1.7 Geographical variation in mortality from suicide and self-infl icted injuries 
in Europe, both genders, all ages, in quintiles, ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
Book 1.indb   9 12/02/2013   11:07
10 Successes and failures of health policy in Europe
They also include the failure to manage the use of antibiotics in health care 
facilities, leading to the emergence of antibiotic resistance.
So far, this analysis has looked at deaths from specifi c causes. It is also 
informative to look at deaths associated with the processes of giving birth 
and being born. Historically, this was an extremely dangerous process. Much 
can go wrong, and a failure to recognize complications and to deal with them 
swiftly can easily lead to the death of the mother and the child (Richardus 
et al. 2003). Once again, Europe has seen great successes in recent decades. 
Maternal death in some countries is now extremely rare, particularly when 
compared with the still very high rates in many other parts of the world. 
However, in some parts of Europe, there is still considerable room for 
improvement. This is most obviously the case in the countries of the former 
USSR, but there are also unacceptably high rates in some western European 
countries. Similar variations can be seen with neonatal mortality (Fig. 1.9), 
although the available data may underestimate the scale of the problem in 
some countries of the former USSR because of weaknesses in birth registration 
(Badurashvili et al. 2001).
In the next section we examine some of the reasons that have been proposed 
to explain why some countries enjoy better health than others.
Figure 1.8 Geographical variation in mortality from road traffi c accidents in Europe, 
both genders, all ages, in quintiles, ca. 2008
Source: WHO Regional Offi ce for Europe 2012
Note: SDR, standardized mortality rate
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Explaining European health patterns
Economic factors
Research that has sought to explain between-country differences in life 
expectancy or mortality from specifi c causes often starts from the observation 
that aggregate health outcomes tend to be closely correlated with national 
income, typically measured by gross domestic product (GDP). This was fi rst 
described systematically by Preston, who in a seminal paper showed that during 
the 20th century there has always been a strong cross-sectional relationship 
between GDP and life expectancy (Preston 1975). In global comparisons, the 
relationship is steeper at lower than at higher levels of GDP, and this can also be 
observed in Europe in 2008, although even a straight line would do reasonably 
well in summarizing this relationship (Fig. 1.10). Moreover, studies on the 
evolution of mortality over time have shown an association between economic 
growth and mortality from many different causes, such as cardiovascular 
diseases, cerebrovascular disease, cancers, disorders of infancy and motor 
vehicle injuries (Brenner 1987).
Some of the trends and variations in mortality described earlier in this 
chapter were undoubtedly driven by economic development. The western 
Figure 1.9 Geographical variation in neonatal mortality in Europe, both genders, in 
quintiles ca. 2008
Source: WHO Regional Offi ce for Europe 2012
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part of the European region experienced almost continuous economic growth, 
while many countries in the eastern part experienced economic stagnation 
in the 1980s, a result of the failure of the communist economic model and 
outright economic decline in the 1990s, exacerbated by forced restructuring of 
the economy (Stuckler et al. 2009).
This relationship between national income and life expectancy must, however, 
be an indirect one, because as Preston already showed, the relationship has 
shifted upwards over time. At a given level of national income, life expectancy 
was higher in 1960 than in 1930, implying that only part of the rise in national 
life expectancies between 1930 and 1960 could be explained by the rise of 
national incomes (Preston 1975). Similar upward shifts have been seen more 
recently (Bloom and Canning 2007).
The explanation is that the mechanisms that link economic development 
to improved health outcomes are only partly dependent on average income 
levels. Sanitary measures that were at one time attainable only for countries 
with the highest levels of development have spread to other countries even 
before these countries reached the same income levels, because the knowledge 
was freely available and the required technical equipment became cheaper over 
time (P reston 1975; Mackenbach 2007). The same is likely to be true for the 
health policies of today.
As this book focuses on the role of collective human agency in explain-
ing health variations within Europe, we will now briefl y review some of the 
Figure 1.10 Association between gross domestic product (GDP in US$) and life 
expectancy at birth in Europe, 2008
Source: WHO Regional Offi ce for Europe 2012
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previous studies looking at the impact of policy variations on health outcomes. 
These studies can be divided in two groups: studies that focus on specifi c health 
outcomes from which policy impacts are inferred indirectly, and studies that 
directly relate policy exposures to health outcomes. We will limit ourselves to 
studies that have looked at a broad range of health outcomes; where relevant, 
disease-specifi c studies will be reviewed in subsequent chapters.
Indirect studies
If one can identify specifi c health outcomes that are likely to be infl uenced 
mainly by a particular policy, then one can use trends or geographical variations 
in these outcomes to infer the contribution of a particular policy even without 
explicitly linking outcomes to policy exposures.
One example of this approach can be found in the area of ‘amenable mortality’. 
Several decades ago it was proposed that rates of mortality from certain causes 
that are amenable to medical care could be used as indicators of the effectiveness 
of health care. This gave rise to the concept of ‘avoidable’ or ‘amenable’ mortality, 
originally developed by Rutstein et al. (1976) for application in a clinical context, 
and operationalized for application at the population level by Holland and 
colleagues (Charlton et al. 1983; Charlton et al. 1987; Holland 1990). Causes of 
death that are often used in these analyses include tuberculosis, other infectious 
diseases, Hodgkin’s disease, testicular cancer, cervical cancer, cerebrovascular 
disease, appendicitis and maternal and perinatal mortality. Some of these causes 
are amenable to prevention, others to treatment. 
In advanced industrialized countries, including those in the western part 
of the European region, mortality from most of these conditions has declined 
strongly over time in the period covered by this book (Nolte and McKee 2003, 
2004, 2008). The declines have also been used to estimate the contribution of 
improvements in health care to total mortality decline during the 20th century 
(Mackenbach 1996).
Similarly, variations between countries in rates of mortality from amenable 
conditions have been interpreted as indicating differences between countries 
in the performance of their health systems (Nolte and McKee 2003, 2004, 
2008). However, they show only weak relationships with health care supply 
or expenditure (Mackenbach et al. 1990; Mackenback 1991; OECD 2010). 
Nevertheless, they do suggest that some of the observed variations in mortality 
within Europe result from variations in the performance of health care systems.
Declines in amenable mortality have been much smaller in the eastern part 
of the region, and current levels of amenable mortality are considerably higher, 
suggesting that part of the health disadvantage in that part of Europe is a 
refl ection of defi ciencies in health care (Jozan and Prokhorskas 1997; Andreev 
et al. 2003).
Another example of an indirect approach can be found in a range of studies 
looking at the contribution of specifi c risk factors to trends in mortality or 
variations in mortality across countries. Because some of these variations in risk 
factors refl ect the success or failure of policies to tackle them, such analyses can 
be used to generate hypotheses on the population health impact of these policies.
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One of the earliest attempts to do this used data from the World Health 
Organization (WHO) MONICA study, undertaken in 38 populations from 
21 countries between the mid-1980s and 1990s. Although this was the most 
exhaustive survey of the risk factors for cardiovascular diseases to date, it 
contained limited information on treatment. Nonetheless, it concluded that 
preventive measures to reduce exposure to risk factors had made a substantial 
contribution to the observed decline in cardiovascular mortality over the period 
of the study. Subsequent work has used increasingly sophisticated models with 
much more detailed data (Capewell et al. 1999). Examples involve work using 
the IMPACT model (Ainsworth et al. 2011) and, more recently, the DYNAMO 
model (Kulik et al. 2012). The IMPACT model has now been applied to data 
from many countries worldwide. Although the relative contribution varies, it 
identifi es both reduction in risk factors and expansion of effective treatment as 
playing important roles (Unal et al. 2003; Aspelund et al. 2010; Bandosz et al. 
2012). An example of a study of geographical variation is the Intersalt study, 
showing an association between salt intake and blood pressure, both among 
individuals and across countries (Elliott et al. 1996). Collectively, these studies 
suggest that part of the variation in mortality in Europe results from risk factors 
amenable to health policy.
Direct studies
Studies that have sought to examine the relationship between policies and 
population health outcomes directly have largely focused on three different 
policy areas: political regimes, social policies and health care policies. Research 
on political regimes has looked primarily at two different aspects: democratic 
versus authoritarian rule and the political composition of governments.
Democracy may be important for health for several reasons, for example 
because a democratic government is held accountable for its actions and there 
may be stronger mechanisms for selecting competent and honest people (Besley 
and Kudamatsu 2006). A recent overview of 20 studies of the effect of democratic 
government on population health outcomes shows that most, but not all, found 
a positive association, with various controls for other determinants (Klomp and 
de Haan 2009). As many of these studies include a wide range of countries 
with a similarly wide range of political regimes, including many low-income 
countries, it is unclear whether the smaller variation in degrees of democracy 
observed in Europe today may actually contribute to the observed differences 
in health.
Political composition of governments may be equally relevant. It is often 
thought that social democratic governments are more committed to the 
expansion of the welfare state and to other social policies that are conducive to 
health (Borrell et al. 2007). One analysis did indeed fi nd a correlation between 
cumulative years of government by ‘pro-redistributive parties’ on the one hand 
and infant mortality and life expectancy on the other hand, but this study 
did not control for confounding factors (Navarro et al. 2003, 2006). Another 
has found an association between the proportionality of the electoral system 
and both infant mortality and life expectancy, suggesting that, as proportional 
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voting systems encouraged the election of coalitions, the resulting governments 
are more likely to represent the interests of all members of society and not just 
one section (Wigley and Akkoyunlu-Wigley 2011). It is unclear, at the current 
state of our knowledge, whether one should expect an important contribution 
of political composition of governments to the explanation of inequalities in 
health within the European region.
Other research has looked at the effectiveness of governments, often 
captured in a range of measures of the quality of governance. For example, one 
study has demonstrated a positive association between good governance and 
health outcomes in a sample of 101 countries, but it used structural equation 
modelling to show that this is mediated through the effect of governance on 
income and the quality of the health system (Klomp and de Haan 2008).
An area of policy that has attracted a lot of interest recently is that of social or 
welfare policies. Within Europe, countries differ signifi cantly in their approach 
to these policies. The differences have been summarized in the form of three 
(sometimes four) different ‘welfare regimes’: a Nordic or social democratic, 
an Anglo-Saxon or liberal, and a continental or Christian-democratic regime 
(Esping-Andersen 1990); to these three a Mediterranean or family-based regime 
has sometimes been added (Ferrera 1996).
The Nordic welfare states can be characterized by three common features: 
they are comprehensive, institutionalized and universalistic. As most Nordic 
countries also have high life expectancy, researchers have asked whether the 
two are indeed related. A recent analysis of 17 countries, including many in 
Europe, found that social spending and universalism, controlling for GDP, were 
related positively to life expectancy. In more detailed analyses, they found that 
generosity in family policies was associated with lower infant mortality, and 
that generosity in basic pensions lowers old age mortality (Lundberg et al. 2008; 
Kangas 2010). While these and similar analyses of aggregate health measures 
such as total mortality provide indications of potentially relevant relationships, 
they do not elucidate the mechanisms underlying them, and it, therefore, 
remains unclear whether the associations represent causal effects.
The most frequently investigated relationship, however, is that between 
health care and population health indicators. One of the earliest studies, by 
Cochrane and colleagues (1978), sought associations between health system 
‘outputs’, such as mortality at different ages and maternal deaths, and ‘inputs’, 
grouped into social and economic factors, lifestyle factors and health system 
inputs. They found some intuitive results, such as more nurses per head of 
population being associated with lower maternal and infant mortality, but also 
some counterintuitive ones, such as more doctors being associated with higher 
mortality at younger ages.
Since then, many similar studies have been undertaken. However, many 
include samples of countries worldwide and, given the lack of data on adult 
mortality outside developed countries, they have used measures of infant, 
maternal and under-fi ve mortality as their measures of health outcome. 
These analyses also include countries with a much larger range of variation in 
resources than is seen in Europe. The studies also vary considerably in terms 
of the sophistication with which they have taken account of data limitations 
and methodological challenges. Many show a strong association between the 
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density of qualifi ed health workers and health outcomes, typically showing a 
closer association with maternal mortality than with child mortality (Anand 
and Barnighausen 2004).
Fewer studies have looked for associations in developed countries. Hitiris and 
Posnett (1992) found a small negative association between health expenditure 
and crude mortality rates, but they controlled for few other factors. A more 
detailed study found that higher health expenditures in western European 
countries were associated with lower infant and female mortality and, at any 
given level of expenditure, countries with tax-based health systems achieved 
lower infant mortality rates than those with social insurance (Elola et al. 1995). 
Other studies in individual countries also found associations between health 
expenditure and health outcomes (Collins and Klein 1980; Forbes and McGregor 
1984). However, all these studies had limitations, including a failure to account 
for what expenditure could buy in terms of health system inputs. A more 
complex analysis, undertaken by the Organisation for Economic Co-operation 
and Development (OECD), disentangled many of the determinants of health 
and, while fi nding that sociodemographic factors such as education levels and 
national income were the most important drivers of potential years of life lost 
(PYLLs), it also found a signifi cant association with health expenditure, but 
only for females (Or 2000). It was suggested that this refl ected the differing 
pattern of causes of death between men and women, with the former being 
dominated by injuries and violence that were less amenable to medical care.
Collectively, these studies suggest that some of the differences between 
European countries in population health indicators may be related to varying 
political conditions, social policies and levels of health care expenditure. As 
these may all be associated with the health policies that are the focus of this 
book, they should be taken into account when we search for the health impact 
of these policies.
The scope of this book
The variations in health trends described earlier in this chapter raise impor-
tant questions. Many countries in Europe have seen their health situation 
improve dramatically over the past decades, but to what extent did this result 
from purposeful action to improve health, or was it a side-effect of improvements 
in living conditions and health behaviours that came about spontaneously? 
Some countries have seen equally dramatic setbacks. To what extent were 
these the result of deteriorating living conditions or health behaviours, or a 
breakdown of previously successful programmes to tackle health risks? And 
to the extent that these favourable or unfavourable health trends refl ect the 
success or failure of health-related policies, why do some countries perform 
better than others?
These are the types of question that this book has addressed. More systemati-
cally, this book has the following aims, to:
•  assess the extent to which different European countries vary in the imple-
mentation of health policies that are known to be effective
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•  assess the extent to which differences between European countries in imple-
mentation of health policies have had an impact on trends and levels of 
relevant health outcomes
•  identify ‘best practices’ of health policy, and indicate opportunities for further 
health gains by implementing these ‘best practice’ policies throughout 
Europe
•  identify determinants of successes and failures of health policy, and derive 
guidance for policy-makers on how to achieve optimal results.
We defi ne health policies as ‘decisions, plans and actions that are undertaken 
to achieve specifi c health goals within a society’. It is irrelevant whether 
these policies originate within or outside the health care sector, or whether 
they are initiated by public or private institutions. The defi ning characteris-
tics of the ‘decisions, plans and actions’ are that they explicitly aim to pre-
vent or ameliorate health problems, or to reduce exposure to well-known 
health risks, and that they are taken on a population-wide basis (‘within a 
society’).
Importantly, unlike the often cited defi nition of the WHO (‘decisions, plans, 
and actions that are undertaken to achieve specifi c health care goals within 
a society’ (World Health Organization 2012)), our defi nition does not limit 
health policy to actions that imply initiation by, or delivery of, health care. We 
conceptualize health policy as including policies on health care but having a 
much broader scope.
In this book we have limited ourselves to health policies that are based 
on primary or secondary prevention. We considered that there is already an 
abundance of international comparisons of health care policy, focusing on 
differences between countries in how health care systems are organized and how 
health care is fi nanced, to which we have ourselves contributed a substantial 
amount. Readers seeking more information on this topic may fi nd the web site 
of the European Observatory on Health Systems and Policies (2012) a useful 
starting point. We believe that it will be more useful to focus on how countries 
differ in policies that aim at preventing health problems, because this is an area 
that is studied much less often and yet may be of equal or greater relevance for 
improving population health outcomes.
We will deal with both methods of primary prevention (aiming to avoid the 
occurrence of disease by reducing exposure to health risks or by strengthening 
individuals’ ability to cope with these health risks) and methods of secondary 
prevention (aiming to avoid the progression of disease to a symptomatic stage, 
by diagnosing and treating disease in early stages before it causes signifi cant 
morbidity). Other terms that we will sometimes use to distinguish between 
different approaches of prevention are health protection (methods that provide 
passive protection against health risks and do not involve individuals’ active 
participation) and health promotion (methods that enable people to increase 
control over their health and its determinants).
This book will cover 11 areas of health policy that have been identifi ed in 
preliminary analyses as having contributed to major population health gains 
in at least some European countries. These are tobacco; alcohol; food and 
nutrition; fertility, pregnancy and childbirth; child health; infectious diseases; 
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hypertension detection and treatment; cancer screening; mental health; road 
safety; and air pollution.
For each of these areas, similar analyses have been carried out using the 
following general approach. First, reviews were carried out to search and 
grade scientifi c evidence on the effectiveness of potentially relevant policies. 
Second, data were collected on the actual implementation of these policies in 
different European countries, and analyses were made of the impact of these 
policies on health outcomes. Sometimes these analyses could cover a range 
of countries and allowed an assessment of the statistical association between 
policy implementation and policy outcomes. At other times, these analyses 
were conducted in the form of case studies covering single countries. Third, 
the possible determinants of between-country differences in implementation 
of effective health policies were explored. All analyses were limited to 
health policies that may have affected population health in the period 
1970–2010.
The fi nal part of the analysis consisted of a systematic between-country 
analysis. The evidence collected in the 11 area-specifi c analyses was synthesized 
to provide an overview of the generic effectiveness of national health policies, 
seeking to identify countries whose overall success was better than might be 
expected given other factors known to infl uence health policies. Using these 
‘best practices’, the potential population health impacts of implementing ‘best 
practices’ throughout Europe were estimated. An exploration was then carried 
out to identify the governance conditions that are associated with successful 
health policy. Finally, implications for policy-makers were formulated. The 
results of these syntheses are presented in the fi nal fi ve chapters of this book.
The area-specifi c analyses were commissioned from experts in the fi eld. 
Outlines for these chapters were discussed during an author workshop hosted 
by the European Public Health Conference in Copenhagen in November 2011. 
Draft versions of chapters were edited into the fi nal versions appearing in this 
book during a residency by the editors at the Rockefeller Foundation’s Bellagio 
Centre in April/May 2012. This residency also allowed the editors to write the 
introduction and fi nal fi ve chapters of this book.
A fi nal word is needed about the boundaries of Europe as applied in this 
book. It is far from obvious how Europe should be defi ned. It is part of the Eurasian 
land mass, with the border with Asia a question of culture and history as much 
as of physical geography. This was already noted dismissively by Metternich, 
who suggested that Asia began on the outskirts of Vienna. Two partly European 
countries, Turkey and the Russian Federation, have the largest parts of their 
land masses in Asia, and both simultaneously draw on cultural traditions 
from east and west. The European Region of the WHO stretches from western 
Greenland to Vladivostok and includes a number of countries that are 
unambiguously in Asia, such as Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan 
and Israel. For the purposes of this book, we have taken a pragmatic approach, 
defi ning Europe as those countries that are part of the WHO’s European 
Region, minus Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Israel and 
Turkey. When we further exclude the mini-states of Andorra, Liechtenstein, 
Monaco, San Marino and the Vatican City, this gives us 43 nations to consider 
in this book.
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Notwithstanding our European focus, we hope and expect that this book 
will be useful for public health practitioners, health policy-makers and public 
health scientists both in Europe and elsewhere.
References
Ainsworth, J.D., Carruthers, E., Couch, P. et al. (2011) IMPACT: a generic tool for modelling 
and simulating public health policy, Methods in Information Medicine, 50(5):454–63.
Anand, S. and Barnighausen, T. (2004) Human resources and health  outcomes: cross-
country econometric study, Lancet, 364(9445):1603–9.
Andreev, E.M., Nolte, E., Shkolnikov, V.M. et al. (2003) The  evolving pattern of avoidable 
mortality in Russia, International Journal of Epidemiology, 32(3):437–46.
Aspelund, T., Gudnason, V., Magnusdottir, B.T. et al. (2010) Anal ysing the large decline in 
coronary heart disease mortality in the Icelandic population aged 25–74 between the 
years 1981 and 2006, PLoS One, 5(11):e13957.
Badurashvili, I., McKee, M., Tsuladze, G. et al. (20 01) Where there are no data: what has 
happened to life expectancy in Georgia since 1990? Public Health, 115(6):394–400.
Bandosz, P., O’Flaherty, M., Drygas, W. et al. (2012) Decline in mortality from coronary 
heart dis ease in Poland after socioeconomic transformation: modelling study, British 
Medical Journal, 344:d8136.
van Beeck, E.F., Borsboom, G.J. and Mackenbach, J.P. (2000) Econ omic development and 
traffi c accident mortality in the industrialized world, 1962–1990, International Journal 
of Epidemiology, 29(3):503–9.
Berkey, C.S., Willett, W.C., Frazier, A.L. et al. (2011 ) Prospective study of growth and 
development in older girls and risk of benign breast disease in young women, Cancer, 
117(8):1612–20.
Besley, T. and Kudamatsu, M. (2006) Health and democracy, Poli tical Economy, 
96(2):313–18.
Bloom, D.E. and Canning, D. (2007) Commentary: the Preston curve 30 years on: still 
sparking fi res, International Journal of Epidemiology, 36:498–9; discussion 502–3.
Borrell, C., Espelt, A. and Rodriguez-Sanz, M. (20 07) Politics and health, Journal of 
Epidemiology and Community Health, 61(8):658–9.
Brenner, M.H. (1987) Relation of economic change to Swedish health and social well-
being, 1950–1980, Social Science and Medicine, 25(2):183–95.
Capewell, S., Pell, J.P., Morrison, C. and McMurray, J. (19 99) Increasing the impact 
of cardiological treatments. How best to reduce deaths, European Heart Journal, 
20(19):1386–92.
Charlton, J.R., Hartley, R.M., Silver, R. and Holland, W.W. (1983) Geographi cal variation 
in mortality from conditions amenable to medical intervention in England and 
Wales, Lancet, i(8326):691–6.
Charlton, J.R., Holland, W.W., Lakhani, A. and Paul, E.A. (1987 ) Variations in avoidable 
mortality and variations in health care, Lancet, i(8537):858.
Cochrane, A.L., St Leger, A.S. and Moore, F. (19 78) Health service ‘input’ and mortality 
‘output’ in developed countries, Journal of Epidemiology and Community Health, 
32(3):200–5.
Collins, E. and Klein, R. (1980) Equity and the NHS: sel f-reported morbidity, access, and 
primary care, British Medical Journal, 281(6248):1111–15.
Elliott, P., Stamler, J., Nichols, R. et al. (1996) I ntersalt revisited: further analyses of 
24 hour sodium excretion and blood pressure within and across populations. Intersalt 
Cooperative Research Group, British Medical Journal, 312(7041):1249–53.
Book 1.indb   19 12/02/2013   11:07
20 Successes and failures of health policy in Europe
Elola, J., Daponte, A. and Navarro, V. (19 95) Health indicators and the organization of 
health care systems in western Europe, American Journal of Public Health, 
85(10):1397–1401.
Esping-Andersen, G. (1990) The Three Worlds  of Welfare Capitalism. Cambridge, UK: Polity 
Press.
European Observatory on Health Systems and Policies (201 2) Website. London: European 
Observatory on Health Systems and Policies, http://www.euro.who.int/en/who-we-
are/partners/observatory (accessed 4 June 2012).
Ferrera, M. (1996) Southern model of welfare in social Europe, Journal of European Social 
Policy, 6/1:17–37.
Forbes, J.F. and McGregor, A. (1984) Unemployment and mortality  in post-war Scotland, 
Journal of Health Economics, 3(3):239–57.
Ford, E.S. and Capewell, S. (2011) Proportion of the decline in cardiovascular mortality 
disease due to prevention versus treatment: public health versus clinical care, Annual 
Review of Public Health, 32:5–22.
Gilmore, A.B. and McKee, M. (2004) Moving east: how the tran snational tobacco industry 
gained entry to the emerging markets of the former Soviet Union. Part I: establishing 
cigarette imports, Tobacco Control, 13(2):143–50.
Gonzalez, E.L., Johansson, S., Wallander, M.A. and Rodríguez, L.A. (2009) Trends in the 
prevalence and incidence of diabetes in the UK: 1996–2005, Journal of Epidemiology 
and Community Health, 63(4):332–6.
Hirte, L., Nolte, C. Bain, E., and McKee, M. (200 7) Breast cancer mortality in Russia 
and Ukraine 1963–2002: an age-period cohort analysis, International Journal of 
Epidemiology, 36(4):900–6.
Hitiris, T. and Posnett, J. (1992) The determinants and effects of health expenditure in 
developed countries, Journal of Health Economics, 11(2):173–81.
Holland, W. (1990) Avoidable  death as a measure of quality, Quality Assurance in Health 
Care, 2(3–4):227–33.
Human Life-Table Database (201 2) website. Munich: Max-Planck-Gesellschaft, http://
www.lifetable.de (accessed 4 June 2012).
Jozan, P. and Prokhorskas, R. (1997) Atlas of Leading and ‘Avoidable’ Cause of Death in 
Countries of Central and Eastern Europe. Budapest: Hungarian Central Statistical Offi ce 
Publishing.
Kangas, O. (2010) One hundr ed years of money, welfare and death: mortality, economic 
growth and the development of the welfare state in 17 OECD countries 1900–2000, 
International Journal of Social Welfare, 19:S42–S59.
Klomp, J. and de Haan, J. (2008) Effects of governance on health: a cross-national analysis 
of 101 countries, Kyklos, 61:599–614.
Klomp, J. and de Haan, J. (2009) Is the political system  really related to health? Social 
Science and Medicine, 69(1):36–46.
Kulik, M.C., Nusselder, W.J., Boshuizen, H.C. et al. (201 2) Comparison of tobacco control 
scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA 
modeling tool, PLoS One, 7(2):e32363.
Lundberg, O., Yngwe, M.A., Stjärne, M.K. et al. (2008) The role of welfare state principles 
and generosity in social policy programmes for public health: an international 
comparative study, Lancet, 372(9650):1633–40.
Mackenbach, J.P. (1991) Health care expe nditure and mortality from amenable conditions 
in the European Community, Health Policy, 19(2–3):245–55.
Mackenbach, J.P. (1994) The epidemiologi c transition theory, Journal of Epidemiology and 
Community Health, 48(4):329–31.
Mackenbach, J.P. (1996) The contribution of medical care to mortality decline: McKeown 
revisited, Journal of Clinical Epidemiology, 49(11):1207–13.
Book 1.indb   20 12/02/2013   11:07
Introduction  21
Mackenbach, J.P. (2007) Commentary: did  Preston underestimate the effect of economic 
development on mortality? International Journal of Epidemiology, 36(3):496–7; 
discussion 498–502.
Mackenbach, J.P., Bouvier-Colle, M.H. and Jougla, E. (1990 ) Avoidable mortality and 
health services: a review of aggregate data studies, Journal of Epidemiology and 
Community Health, 44(2):106–11.
McKee, M., Zwi, A., Koupilova, I., Sethi, D. and Leon, D. (2000) Health policy-making in 
central and eastern Europe: lessons from the inaction on injuries? Health Policy Plan, 
15(3):263–9.
Meslé, F. and Vallin, J. (2006) Diverging trends in fema le old-age mortality: the United 
States and the Netherlands versus France and Japan, Population and Development 
Review, 32(1):123–45.
Navarro, V., Borrell, C., Benach, J. et al. (2003) The  importance of the political and the 
social in explaining mortality differentials among the countries of the OECD, 1950–
1998, International Journal of Health Services, 33(3):419–94.
Navarro, V., Muntaner, C., Borrell, C. et al. (2006) Politics and health outcomes, Lancet, 
368(9540 ):1033–7.
Nolte, C.M. and McKee, M. (2003) Measuring the health of na tions: analysis of mortality 
amenable to health care, British Medical Journal, 327(7424):1129.
Nolte, C.M. and McKee, M. (2004) Does Health Care Save Live s? Avoidable Mortality Revisited. 
London: Nuffi eld Trust.
Nolte, C.M. and McKee, M. (2008) Measuring the health of na tions: updating an earlier 
analysis, Health Affairs (Millwood), 27(1):58–71.
OECD (2010) Healt h Care Systems: Effi ciency and Policy Settings. Paris: Organisation for 
Economic Co-operation and Development.
Olshansky, S.J. and Ault, A.B. (1986) The fourth stage of the epidemi ologic transition: the 
age of delayed degenerative diseases, Milbank Quarterly, 64(3):355–91.
Omran, A.R. (1971) The epidemiologic transition. A theory of the epidemiology of 
population change, Milbank Quarterly, 49(4):509–38.
Omran, A.R. (1983) The epidemio logic transition theory. A preliminary update, Journal of 
Tropical Pediatrics, 29(6):305–16.
Or, Z. (2000) Determi nants of Health Outcomes in Industrialised Countries: A Pooled, Cross-
country, Time-series Analysis. [OECD Economic Studies 30.] Paris: Organisation for 
Economic Co-operation and Development.
Patterson, C.C., Dahlquist, G.G. and Gyürüs, E., for the EURODIAB Study Group (2009) 
Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and 
 predicted new cases 2005–20: a multicentre prospective registration study, Lancet, 
373(9680):2027–33.
Preston, S.H. (1975) The changing rel ation between mortality and level of economic 
development, Population Studies, 29(2):231–48.
Richardus, J.H., Graafmans, W.C., Verloove-Vanhorick, S.P. and Mackenbach, J.P. (2003) 
Dif ferences in perinatal mortality and suboptimal care between 10 European regions: 
results of an international audit. BJOG: An International Journal of Obstetrics and 
Gynaecology, 110(2):97–105.
Riley, J.C. (2001) Rising Life Ex pectancy. A Global History. Cambridge, UK: Cambridge 
University Press.
Rutstein, D.D., Berenberg, W., Chalmers, T.C. et al. (1976) Me asuring the quality 
of medical care. A clinical method, New England Journal of Medicine, 294(11):
582–8.
Seitz, H.K., Pelucchi, C., Bagnardi, V. and La Vecchia, C. (2012) E pidemiology and 
pathophysiology of alcohol and breast cancer: update 2012, Alcohol and Alcoholism, 
47(3):204–12.
Book 1.indb   21 12/02/2013   11:07
22 Successes and failures of health policy in Europe
Sonnenberg, A. (2010) Differences in th e birth-cohort patterns of gastric cancer and 
peptic ulcer, Gut, 59(6):736–43.
Stuckler, D., Basu, S., McKee, M. and King, L. (2008) Mass incarceration can explain 
population increases in TB and multi-drug resistant TB in European and central Asian 
countries, Proceedings of the National Academy of Sciences USA, 105(36):13280–5.
Stuckler, D., King, L. and McKee, M. (2009) M ass privatisation and the post-communist 
mortality crisis: a cross-national analysis, Lancet, 373(9661):399–407.
Suhrcke, M., Stuckler, D., Suk, J.E. et al. (2011) The impact of economic crises on 
communicable disease transmission and control: a systematic review of the evidence, 
PLoS One, 6(6):e20724.
Thun, M., Peto, R., Boreham, J. and Lopez, A.D. (2012) St ages of the cigarette epidemic on 
entering its second century, Tobacco Control, 21(2):96–101.
Tomkins, S., Collier, T., Oralov, A. et al. (2012) Ha zardous alcohol consumption is a major 
factor in male premature mortality in a typical Russian city: prospective cohort study 
2003–2009, PLoS One, 7(2):e30274.
Unal, B., Critchley, J. and Capewell, S. (2003) I mpact of smoking reduction on coronary 
heart disease mortality trends during 1981–2000 in England and Wales, Tobacco 
Induced Disease, 1(3):185.
Vallin, J. and Meslé, F. (2004) Convergences and divergence s in mortality. A new approach 
to health transition. Demographic Research, Special Collection 2(Article 2):11–44, 
http://www.demographic-research.org/special/2/2/ (accessed 4 June 2012).
Vallin, J., Meslé, F., Adamets, S. and Pyrozhkov, S. (2002) A new estimate of Ukrainian 
population losses during th e crises of the 1930s and 1940s, Population Studies (Camb), 
56(3):249–63.
Wigley, S. and Akkoyunlu-Wigley, A. (2011) Do electoral institutions have an impac t on 
population health? Public Choice, 148:595–610.
WHO Regional Offi ce for Europe (2012) European Health for All Database (HFA-DB). 
Copenhagen: WHO Regional Offi ce for Europe, http://data.euro.who.int/hfadb/ 
(accessed 4 June 2012).
World Health Organization (2012) [website]. Geneva: World Health Organization, http://
www.who.int/topics/health_policy/en/ (accessed 4 June 2012).
Book 1.indb   22 12/02/2013   11:07
